Kelan G. Tantisira, M generic levitra .D., Jessica Lasky-Su, Sc.D., Michishige Harada, Ph.D., Amy Murphy, Ph.D., Augusto A. Litonjua, M.D., Blanca E. Himes, Ph.D., Christoph Lange, Ph.D., Ross Lazarus, M.B., B.S., Jody Sylvia, B.S., Barbara Klanderman, Ph.D., Qing Ling Duan, Ph.D., Weiliang Qiu, Ph.D., Tomomitsu Hirota, Ph.D., Fernando D. Martinez, M.D., David Mauger, Ph.D., Christine Sorkness, Pharm.D., Stanley Szefler, M.D., Stephen C. Lazarus, M.D., Robert F. Lemanske, Jr., M.D., Stephen P. Peters, M.D., Ph.D., John J. Lima, Pharm.D., Yusuke Nakamura, M.D., Ph.D., Mayumi Tamari, M.D., Ph.D., and Scott T. Weiss, M.D.: Genomewide Association between GLCCI1 and Response to Glucocorticoid Therapy in Asthma Asthma is a complex genetic syndrome that impacts 300 million persons worldwide.1 The response to treatment can be genetically complicated and is seen as a high intraindividual repeatability2 and high interindividual variability,3 with up to 40 percent of patients with asthma having no response to therapy.
Bauman added that improving current preparedness to handle such strokes is ‘more likely to require educating healthcare companies and the scientific community about cryptogenic stroke, appropriate work-up, applicable outcomes and studies.’ Bauman said that stroke happens to be the fifth-leading cause of death in the United States, and a leading reason behind severe and long-term disability. Every full year, about 200,000 Americans experience a stroke that appears to elude explanation, the researchers added. Possible underlying causes range from an intermittent and hard-to-identify irregular heartbeat , a blood clot disorder and/or a hole in the heart’s upper chambers, according to background information in the news release.